Pasithea Therapeutics Aktie
WKN DE: A3C3B5 / ISIN: US70261F1030
|
04.05.2026 13:37:06
|
Pasithea Therapeutics Appoints Kartik Krishnan As CMO
(RTTNews) - Pasithea Therapeutics Corporation (KTTA) said on Monday that it has appointed Kartik Krishnan as chief medical officer with effect from May 1.
Krishnan has over 20 years of experience in clinical development, pharmacovigilance, clinical operations, and others.
Prior to joining Pasithea, Krishnan was chief executive officer at OncoNano Medicines, a privately held company developing anti-cancer assets.
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Pasithea Therapeutics Corp Registered Shs
| Keine Nachrichten verfügbar. |